Trial Profile
Efficacy of PX 1041 in patients with metastatic breast cancer
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 23 Aug 2006
Price :
$35
*
At a glance
- Drugs PX 1041 (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Pharmexa
- 23 Aug 2006 Status change
- 15 Dec 2005 New trial record.